146 related articles for article (PubMed ID: 34369213)
1. Blood suPAR, Th1 and Th17 cell may serve as potential biomarkers for elderly sepsis management.
Zhao L; Yu S; Wang L; Zhang X; Hou J; Li X
Scand J Clin Lab Invest; 2021 Oct; 81(6):488-493. PubMed ID: 34369213
[TBL] [Abstract][Full Text] [Related]
2. Th17, rather than Th1 cell proportion, is closely correlated with elevated disease severity, higher inflammation level, and worse prognosis in sepsis patients.
Liu Y; Wang X; Yu L
J Clin Lab Anal; 2021 May; 35(5):e23753. PubMed ID: 33704828
[TBL] [Abstract][Full Text] [Related]
3. Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor.
Giamarellos-Bourboulis EJ; Norrby-Teglund A; Mylona V; Savva A; Tsangaris I; Dimopoulou I; Mouktaroudi M; Raftogiannis M; Georgitsi M; Linnér A; Adamis G; Antonopoulou A; Apostolidou E; Chrisofos M; Katsenos C; Koutelidakis I; Kotzampassi K; Koratzanis G; Koupetori M; Kritselis I; Lymberopoulou K; Mandragos K; Marioli A; Sundén-Cullberg J; Mega A; Prekates A; Routsi C; Gogos C; Treutiger CJ; Armaganidis A; Dimopoulos G
Crit Care; 2012 Aug; 16(4):R149. PubMed ID: 22873681
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational study.
Liu X; Shen Y; Li Z; Fei A; Wang H; Ge Q; Pan S
BMC Anesthesiol; 2016 Jul; 16(1):46. PubMed ID: 27473112
[TBL] [Abstract][Full Text] [Related]
5. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.
Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B
J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228
[TBL] [Abstract][Full Text] [Related]
6. The correlation between Jun N-terminal kinase pathway-associated phosphatase and Th1 cell or Th17 cell in sepsis and their potential roles in clinical sepsis management.
Yu D; Peng X; Li P
Ir J Med Sci; 2021 Aug; 190(3):1173-1181. PubMed ID: 33083958
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
[TBL] [Abstract][Full Text] [Related]
8. Serum plasminogen activator urokinase receptor predicts elevated risk of acute respiratory distress syndrome in patients with sepsis and is positively associated with disease severity, inflammation and mortality.
Chen D; Wu X; Yang J; Yu L
Exp Ther Med; 2019 Oct; 18(4):2984-2992. PubMed ID: 31555383
[TBL] [Abstract][Full Text] [Related]
9. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis.
Savva A; Raftogiannis M; Baziaka F; Routsi C; Antonopoulou A; Koutoukas P; Tsaganos T; Kotanidou A; Apostolidou E; Giamarellos-Bourboulis EJ; Dimopoulos G
J Infect; 2011 Nov; 63(5):344-50. PubMed ID: 21839112
[TBL] [Abstract][Full Text] [Related]
10. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.
Suberviola B; Castellanos-Ortega A; Ruiz Ruiz A; Lopez-Hoyos M; Santibañez M
Intensive Care Med; 2013 Nov; 39(11):1945-52. PubMed ID: 23949703
[TBL] [Abstract][Full Text] [Related]
11. LncRNA GAS5 relates to Th17 cells and serves as a potential biomarker for sepsis inflammation, organ dysfunctions and mortality risk.
Zhang W; Chen B; Chen W
J Clin Lab Anal; 2022 May; 36(5):e24309. PubMed ID: 35325494
[TBL] [Abstract][Full Text] [Related]
12. MALT1 positively correlates with Th1 cells, Th17 cells, and their secreted cytokines and also relates to disease risk, severity, and prognosis of acute ischemic stroke.
Chen X; Zhang X; Lan L; Xu G; Li Y; Huang S
J Clin Lab Anal; 2021 Sep; 35(9):e23903. PubMed ID: 34273195
[TBL] [Abstract][Full Text] [Related]
13. Thrombo-inflammatory biomarkers to predict sepsis outcome.
Efat A; Shoeib SA; Arafa AF; Dawod AA; Abd ElHafez MA; Abd ElMohsen EA; Eladly HF; Ibrahim RA; Elkholy A
Int J Immunopathol Pharmacol; 2021; 35():20587384211048561. PubMed ID: 34647483
[TBL] [Abstract][Full Text] [Related]
14. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.
Donadello K; Scolletta S; Taccone FS; Covajes C; Santonocito C; Cortes DO; Grazulyte D; Gottin L; Vincent JL
J Crit Care; 2014 Feb; 29(1):144-9. PubMed ID: 24120089
[TBL] [Abstract][Full Text] [Related]
15. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
[TBL] [Abstract][Full Text] [Related]
16.
Liu B; Ren H; Chen J
Biomark Med; 2021 Sep; 15(13):1177-1186. PubMed ID: 34406030
[No Abstract] [Full Text] [Related]
17. Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis.
Okulu E; Arsan S; Akin IM; Ates C; Alan S; Kilic A; Atasay B
J Clin Lab Anal; 2015 Sep; 29(5):347-52. PubMed ID: 25043869
[TBL] [Abstract][Full Text] [Related]
18. Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients.
Geboers DG; de Beer FM; Tuip-de Boer AM; van der Poll T; Horn J; Cremer OL; Bonten MJ; Ong DS; Schultz MJ; Bos LD
Intensive Care Med; 2015 Jul; 41(7):1281-90. PubMed ID: 26100127
[TBL] [Abstract][Full Text] [Related]
19. Thrombocytopenia in critically ill patients with severe sepsis/septic shock: Prognostic value and association with a distinct serum cytokine profile.
Tsirigotis P; Chondropoulos S; Frantzeskaki F; Stamouli M; Gkirkas K; Bartzeliotou A; Papanikolaou N; Atta M; Papassotiriou I; Dimitriadis G; Dimopoulou I
J Crit Care; 2016 Apr; 32():9-15. PubMed ID: 26726794
[TBL] [Abstract][Full Text] [Related]
20. Soluble Urokinase Plasminogen Activator Receptor: A New Biomarker in the Pediatric Intensive Care Unit.
El-Mekkawy MS; Saleh NY; Sonbol AA
Indian J Pediatr; 2016 Jul; 83(7):661-9. PubMed ID: 26960717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
